Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012

Oncology Clinical Development Congress

10 Oct 2012 - 11 Oct 2012 - Manchester, UK

Bookmark and Share

The global oncology market faces the dual problem of increasing drug development expenses and the high failure rate of oncology drugs. The current ROI in drug development has been estimated to be as low as 0.3%. As experts try to reduce expenses and increase their chances of success, the industry is witnessing an increased emphasis on early decision making, adaptive programme design and strategic clinical alliances.

Over the 2 days, the Oncology Clinical Development Congress will provide a high-level platform for discussing these challenges and hearing case studies from those who have taken great steps in overcoming them. The conference programme consists of 20 world-class keynote addresses, industry and academic led presentations and panel debates, creating an interactive forum for scientific and business debate.

Over the two days, key opinion leaders will explore pioneering solutions and critical opportunities in areas such as targeted therapeutics, clinical imaging and operations management. On Day 1, our internationally recognised experts will discuss strategies for co-developing combined therapies, establishing clear endpoints and building successful clinical partnerships. On Day 2, delegates will hear from those working at the forefront of trial design, patient selection and clinical outsourcing.

Further information
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos